Skip to main content

Advertisement

Table 2 Changes in clinical serum chemistry and complete blood count variables

From: Efficacy and safety of a popular thermogenic drink after 28 days of ingestion

Variable Group Day 0 Day 28 Significance
Triglycerides (mg·dl-1) TD PLA 94 ± 8 94 ± 7 105 ± 9 98 ± 7 Group: Time: G × T: 0.77 0.10 0.44
Total Chol (mg·dl-1) TD PLA 162 ± 5 165 ± 6 164 ± 5 168 ± 5 Group: Time: G × T: 0.61 0.32 0.99
HDL Chol (mg·dl-1) TD PLA 58 ± 3 54 ± 2 57 ± 3 54 ± 2 Group: Time: G × T: 0.33 0.92 0.44
LDL Chol (mg·dl-1) TD PLA 85 ± 4 94 ± 6 86 ± 5 94 ± 5 Group: Time: G × T: 0.26 0.73 0.91
Glucose (mg·dl-1) TD PLA 94 ± 1 91 ± 1 96 ± 1 92 ± 1 Group: Time: G × T: 0.07 0.06 0.52
Sodium (mM) TD PLA 141 ± 1 141 ± 1 142 ± 2 142 ± 2 Group: Time: G × T: 0.93 0.03 0.96
Potassium (mM) TD PLA 4.4 ± 0.1 4.5 ± 0.1 4.5 ± 0.1 4.6 ± 0.1 Group: Time: G × T: 0.20 0.41 0.96
BUN (mg·dl-1) TD PLA 14 ± 1 14 ± 1 14 ± 1 13 ± 1 Group: Time: G × T: 0.63 0.35 0.36
Creatinine (mg·dl-1) TD PLA 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 Group: Time: G × T: 0.46 0.007 0.42
ALT (U·L-1) TD PLA 20 ± 2 19 ± 1 18 ± 1 18 ± 1 Group: Time: G × T: 0.69 0.12 0.51
AST (U·L-1) TD PLA 20 ± 1 20 ± 1 20 ± 1 21 ± 2 Group: Time: G × T: 0.94 0.53 0.74
RBC Count (106·μl-1) TD PLA 5.00 ± 0.12 4.91 ± 0.14 4.63 ± 0.08 4.62 ± 0.10 Group: Time: G × T: 0.75 < 0.001 0.68
Hemoglobin (g·dl-1) TD PLA 14.5 ± 0.2 14.8 ± 0.3 14.2 ± 0.2 14.4 ± 0.3 Group: Time: G × T: 0.42 0.003 0.50
Hematocrit (%) TD PLA 43.6 ± 1.6 42.7 ± 0.8 40.8 ± 0.7 41.0 ± 0.9 Group: Time: G × T: 0.78 0.02 0.56
WBC Count (103·μl-1) TD PLA 5.9 ± 0.2 5.9 ± 0.2 5.8 ± 0.2 6.1 ± 0.2 Group: Time: G × T: 0.63 0.95 0.36
  1. TD, thermogenic drink group (n = 30)
  2. PLA, placebo group (n = 30)
  3. Values are expressed as means ± SE
  4. Significant main effect for time, p < 0.05